Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Friday, October 24 2014 8:48pm ET - U.S. Markets Closed.
Industry Center
Industry Center > > Amylin Pharmaceuticals, Inc. Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Amylin Pharmaceuticals, Inc. Company Profile
Amylin Pharmaceuticals helps diabetics gain the upper hand in their battle with the disease. The company makes and markets injectable diabetes drugs Byetta and Symlin, which are approved as adjunct therapies to other diabetes treatments such as metformin and insulin. Byetta is also approved as a stand-alone diabetes therapy. Amylin gained FDA approval for Bydureon, a once-weekly version of Byetta, in 2012, and it is developing additional drugs for metabolic conditions. The company's US sales force markets its products to patients and physicians; development partner Eli Lilly markets Byetta internationally, although Amylin and Lilly are ending their partnership. Amylin was acquired by Bristol-Myers Squibb in 2012.
Contact Information
Address: 9360 Towne Centre Dr.
San Diego, CA 92121
Phone:858-552-2200
Fax:858-552-2212
Financial Highlights
Fiscal Year End:December
Key People
Chairman: Paulo F. Costa
SVP Operations: Paul G. Marshall
SVP Finance and CFO: Mark G. Foletta
Industry Information
Sector:
Industry:
Top Competitors
GlaxoSmithKline plc (gsk)
Merck & Co., Inc. (mrk)
Novo Nordisk A/S (nvo)
 


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?